TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

Author： Volpe Massimo  

Publisher： Adis International

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.16, Iss.1, 2009-05, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities

By Carugo Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

Similarities and Differences between Angiotensin II Type 1 Receptor Antagonists

By Alberto Corsini  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 3, 2004-01 ,pp. : 117-121

Adis International

Access to resources Recommend Favorite

Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?

By AZIZI M.   NICOLET L.   CHATELLIER G.   GUYENE T. T.   HEMPENIUS J.   MÉNARD J.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 53-53

Informa Healthcare

Access to resources Recommend Favorite

Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil

By UNGER THOMAS  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 14-18

Informa Healthcare

Access to resources Recommend Favorite

The Comparative Pharmacology of Angiotensin II Receptor Antagonists

By Burnier Michel   Maillard Marc  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 6-11

Informa Healthcare

Access to resources Recommend Favorite